Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.27M Sell
67,034
-196,677
-75% -$6.32M 0.04% 659
2017
Q2
$8.4M Sell
263,711
-155,886
-37% -$4.92M 0.16% 118
2017
Q1
$13.6M Sell
419,597
-5,692
-1% -$179K 0.45% 21
2016
Q4
$13.1M Buy
425,289
+295,331
+227% +$9.02M 0.31% 42
2016
Q3
$4.18M Sell
129,958
-6,430
-5% -$215K 0.09% 324
2016
Q2
$4.56M Sell
136,388
-174,120
-56% -$5.56M 0.08% 343
2016
Q1
$8.73M Sell
310,508
-117,521
-27% -$3.36M 0.15% 151
2015
Q4
$13.1M Buy
428,029
+267,505
+167% +$8.42M 0.14% 171
2015
Q3
$4.78M Sell
160,524
-37,628
-19% -$1.21M 0.05% 537
2015
Q2
$6.3M Sell
198,152
-58,181
-23% -$1.9M 0.06% 447
2015
Q1
$8.46M Sell
256,333
-204,370
-44% -$6.5M 0.08% 290
2014
Q4
$13.6M Sell
460,703
-36,153
-7% -$1.04M 0.09% 293
2014
Q3
$13.9M Sell
496,856
-293,960
-37% -$8.25M 0.07% 371
2014
Q2
$22.3M Sell
790,816
-130,169
-14% -$3.71M 0.11% 214
2014
Q1
$28.1M Buy
920,985
+611,952
+198% +$18.2M 0.16% 114
2013
Q4
$8.98M Buy
309,033
+96,652
+46% +$2.81M 0.05% 502
2013
Q3
$5.79M Sell
212,381
-1,165,408
-85% -$31.7M 0.04% 638
2013
Q2
$36.6M Buy
+1,377,789
New +$38.1M 0.22% 42

Other funds holding PFE

Spot Trading's PFE Position: Q3 2017 in Review

Spot Trading sold out of Pfizer (PFE) in Q3 2017, closing a stake of 41,298 shares — an estimated $1.33M sold.

Spot Trading first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $30.8M in Q2 2013. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Spot Trading reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 41,298 Pfizer shares in Q3 2017, an estimated $1.33M.
  • Spot Trading first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
  • Spot Trading's Pfizer position peaked at $30.8M in Q2 2013.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.